Wordt geladen...
Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
OnabotulinumtoxinA is being increasingly used in the management of chronic migraine (CM). Treatment with onabotulinumtoxinA poses challenges compared with traditional therapy with orally administered preventatives. The European Headache Federation identified an expert group that was asked to develop...
Bewaard in:
| Gepubliceerd in: | J Headache Pain |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer Milan
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6755553/ https://ncbi.nlm.nih.gov/pubmed/30259200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-018-0921-8 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|